bioRxivImmunology
Extensive substrate recognition by the streptococcal antibody-degrading enzymes IdeS and EndoS
Abstract
Enzymatic cleavage of IgG antibodies is a common strategy used by pathogenic bacteria to ablate immune effector function. The Streptococcus pyogenes bacterium secretes the protease IdeS and the glycosidase EndoS, which specifically catalyse cleavage and deglycosylation of human IgG, respectively. IdeS has received clinical approval for kidney transplantation in hypersensitised individuals, while EndoS has found application in engineering antibody glycosylation. Here, we present crystal structures of both enzymes in complex with their IgG1 Fc substrate, which was achieved using Fc engineering to disfavour preferential Fc crystallisation. The IdeS protease displays extensive Fc recognition and encases the antibody hinge. Conversely, the glycan hydrolase domain in EndoS traps the Fc glycan in a flipped-out conformation, while additional recognition of the Fc peptide is driven by the so-called carbohydrate binding module. Understanding the molecular basis of antibody recognition by bacterial enzymes will facilitate the development of next-generation enzymes for clinical and biotechnological use.
- organism: human
- assay: protein structure
- research focus: protein folding & dynamics
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Bespoke conformation and antibody recognition distinguishes the streptococcal immune evasion factors EndoS and EndoS2
A. S. L. Sudol, I. Tews, M. Crispin·bioRxiv·Aug 15, 2023
- Insights into substrate recognition and specificity for IgG by Endoglycosidase S2
A. H. Aytenfisu, D. Deredge, … A. MacKerell·bioRxiv·May 24, 2021
- Sweet revenge - Streptococcus pyogenes showcases first example of immune evasion through specific IgG glycan hydrolysis
A. Naegeli, E. Bratanis, … M. Collin·bioRxiv·Mar 7, 2019
- An engineered IdeS variant with enhanced activity and performance for IgG degradation
Keyi Zhang, Wenhao Ma, … XC Wu·bioRxiv·Jul 1, 2026
- Streptococcus pyogenes infection and the human proteome with a special focus on the IgG-cleaving enzyme IdeS
C. A. Q. Karlsson, S. Järnum, … J. A. Malmström·bioRxiv·Dec 2, 2017
- Escaping antibody responses to bacteriolytic enzymes Pal and Cpl-1 by epitope scanning and engineering
M. A. Harhala, K. Gembara, … K. Dabrowska·bioRxiv·Oct 6, 2022